Skip to main content
. 2013 Jun 14;14:188. doi: 10.1186/1471-2474-14-188

Table 2.

Proportion of patients, PCPs, and specialists who report each symptom as “Very” or “Extremely” disruptive

 
Patients (%)
PCPs (%)a
Specialists (%) a
Common symptoms Latin America (N = 300) Europe (N = 600) Latin America (N = 253) Europe (N = 503) Latin America (N = 254) Europe (N = 495)
Chronic/Widespread pain
86%*‡
78%
79%
78%
80%
79%
Problems sleeping
80%‡§
76%‡§
70%*
50%
69%*
55%
Fatigue
80%‡§
75%‡§
69%
67%
66%
69%
Headaches
69%‡§
77%*‡§
52%*
37%
45%
38%
Facial pain
59%‡§
69%*‡§
40%*†
24%
30%
27%
Heightened sensitivity to touch
61%‡§
72%*‡§
50%*
42%
48%
49%†
Difficulty concentrating
73%‡§
73%‡§
51%*
36%
50%*
39%
Numbness &/or tingling sensations
59%‡§
62%‡§
48%*†
25%
37%*
24%
Feelings of anxiety
75%*‡§
64%‡§
66%*
44%
64%*
47%
Feelings of depression
73%
77%‡§
74%*
58%
73%*
62%
Joint pain
80%‡§
76%‡§
68%*†
55%
54%
53%
Stiffness
74%‡§
74%‡§
59%*†
39%
44%
39%
Leg cramps
67%*‡§
60%‡§
42%*
24%
35%*
27%
Low back pain 81%*‡§ 75%‡§ 59%*† 44% 50% 45%

a Base case: Physicians currently seeing or have seen patients with FM; * = P < 0.05 Europe vs. Latin America within group (Patient, PCP, Specialist); † P < 0.05 PCP vs. specialist (within region); ‡ P < 0.05 patient vs. PCP (within region); § P < 0.05 patient vs. specialist (within region).